The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench
Immunological Reviews · 2024-10 · 327 (1) · 83-99
DOI: 10.1111/imr.13413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 29.10.2024. Verfasst von Markus J Hofer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Charles Perkins Centre and School of Life and Environmental Sciences, The University of Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Autoimmune Diseases of the Nervous System, Nervous System Malformations, Mutation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Aicardi‐Goutières syndrome (AGS) is a progressive genetic encephalopathy caused by pathogenic mutations in genes controlling cellular anti‐viral responses and nucleic acid metabolism. The mutations initiate autoinflammatory processes in the brain and systemically that are triggered by chronic overproduction of type I interferon (IFN), including IFN‐alpha. Emerging disease‐directed therapies aim to dampen autoinflammation and block cellular responses to IFN production, creating an urgent and unmet need to understand better which cells, compartments, and mechanisms underlying disease pathogenesis. In this review, we highlight existing pre‐clinical models of AGS and our current understanding of how causative genetic mutations promote disease in AGS, to promote new model development and a continued focus on improving and directing future therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charles Perkins Centre and School of Life and Environmental Sciences, The University of Sydney, New South Wales, Australia.
- Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, University of California, San Diego, California, USA.
- Rady Children's Hospital, San Diego, California, USA.
- Sanford Consortium for Regenerative Medicine, San Diego, California, USA.
- Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Mariko L Bennett
Förderung
- National Institute of Allergy and Infectious Diseases
- NINDS NIH HHS
- NIH HHS
- Common Fund
- NIAID NIH HHS
- National Health and Medical Research Council
- Clayco Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Hofer, M. J., Modesti, N., Coufal, N. G., Wang, Q., Sase, S., Miner, J. J., Vanderver, A., & Bennett, M. L. (2024). The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench. Immunological Reviews, 327(1), 83-99. https://doi.org/10.1111/imr.13413
Vancouver
Hofer MJ, Modesti N, Coufal NG, Wang Q, Sase S, Miner JJ, et al. The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench. Immunological Reviews. 2024;327(1):83-99. doi:10.1111/imr.13413
BibTeX
@article{Hofer2024,
author = {Hofer, Markus J and Modesti, Nicholson and Coufal, Nicole G and Wang, Qingde and Sase, Sunetra and Miner, Jonathan J and Vanderver, Adeline and Bennett, Mariko L},
title = {The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench},
journal = {Immunological Reviews},
year = {2024},
volume = {327},
number = {1},
pages = {83--99},
doi = {10.1111/imr.13413}
}
EUVIMED